Deere & Company stock: Raymond James sees a gradual 2027 recovery
Published on 11/18/2026 at 16:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat investors are watching
- Raymond James expects a gradual recovery in large agricultural equipment sales during 2027.
- Dealer feedback remains mixed as crop margins and farm input costs shape replacement demand.
- Growers with strong yields are better positioned to invest, while others are extending equipment lives.
Raymond James retained its Outperform rating and 730 US-dollar price target for Deere & Company after mid-November visits to agricultural equipment dealers across the US Corn Belt, according to Investing.com.
Deere & Company stock traded at 584.90 euros on Lang & Schwarz at 16:04:54 CET on Wednesday, November 18. That was 1.20% below the 592.00-euro quote cited in the earlier report published at 13:28 CET the same day.
Dealer feedback stays mixed
Raymond James analyst Tim Thein found a divided farming backdrop. Livestock profitability was stronger, while tight row-crop margins and higher rented-land costs left some growers cautious about new equipment.
Farmers with good yields and timely crop sales were in a better position to invest. Other operators were extending the working lives of their machinery, limiting near-term replacement demand.
Recovery expected to be gradual
Raymond James expects 2027 to become a recovery year for large agricultural equipment sales. The firm does not anticipate a sharp step-up in North American demand, with fertilizer, diesel and chemical costs weighing on early discussions about next season.
For Deere, the assessment points to a recovery path that remains dependent on farm income, commodity prices and input inflation. The dealer observations offer a near-term gauge of customer confidence ahead of the company's next operating update.
Deere & Company at a glance
- Company: Deere & Company
- ISIN: US2441991054
- NYSE ticker: DE
- Lang & Schwarz quote: 584.90 euros on Wednesday, November 18, 2026, at 16:04:54 CET
- Raymond James view: Outperform
- Raymond James price target: 730 US dollars
US equity investors can follow Current market reports for broader trading developments.
